Raised $3.5 million in startup capital for a small business, designed and built scale production facilities, established supply chain and distribution, and signed-on key national customers.Grew sales 12x from 2016 to 2019.Developed retail channel, including partnerships with Amazon, Costco, REI, Kroger/QFC, Safeway/Albertsons, Bartell Drug, Hudson News, etc.Developed marketing campaign enlisting top American and Sherpa mountaineers as brand ambassadors.Partnered with Patagonia and Outside Magazine/getcairn.com.Featured by TED Vancouver, TEDx Whistler, and NPR.Successfully crowdsourced “Peak Sherpa Energy Bites”, a hiking snack targeting outdoor enthusiasts through resorts and independent outdoor retail channels.Launched multiple products, including breakfast cereals, soups and energy snacks.

CEO and Executive Board Member of Great Himalaya Foods, raising initial seed capital, designing and building production facility in Vancouver, BC.Worked with Washington State University and Oregon State University's research agricultural departments to identify strains of Himalayan style barleys that were or could be grown in North America, and created relationships with local farmers to supply these unique strains of barleys to us.Created a plant floorplan based on a production process flow map, and built a factory based on that map, including foundation modifications, multiple room construction, production equipment installation, new air handling/ventilation systems, overhaul of electrical wiring and installation of storage racking.Established a Board of Directors and enlisted members with food industry expertise, a start up CFO, and an attorney that helped launch Starbucks.Moved company headquarters to the Seattle area, and re-incorporated as Sherpa Foods, SPC.Oversaw Vancouver facility's growth to become North America's largest producer of Tsampa (Himalayan barley cereal).

Provided independent consulting services for several biopharmaceutical companies with early stage (Ph I/II) assets. Projects ranged from identifying therapeutic areas with unmet medical need to shaping development to maximize commercial value.Provided biopharma subject matter expertise for PointB, a management consulting firm based in Seattle.

Managed a portfolio of over 35 early and medium stage pharmaceutical developmental assets. Worked closely with the Business Development Group, to evaluate external assets for in-licensing or the commercial assessment and valuation of internal assetsAssisted in the development of the $60MM co-marketing agreement with Merck for BRINAVESS (vernakalant IV), the most highly valued biotech deal in Canada at the time.Managed cross functional teams of physicians, scientists, regulatory experts, development managers, commercial analysts, and IP attorneys to assess external developmental assets Cardiome considered for acquisition or in-licensing.Developed and maintained preliminary marketing plans for multiple pharmaceuticals in clinical development, tailored by region (US, EU, Japan).Established pricing, access and reimbursement strategy for vernakalant, supporting forecasts which bolstered asset valuation and supported Cardiome’s position in licensing negotiations with Merck. Managed a team of product managers responsible for brand name development, competitive intelligence, forecasting, and market research (primary and secondary).

Specialist focused on marketing strategy, competitive intelligence, channel development and brand planning. Selected for Amgen's Management Development Program, a highly competitive program where recent graduates of top-tier MBA programs are rotated into Sales, Marketing and Market Research roles, supporting multi-billion dollar brands like Enbrel, Aranesp, Prolia, and Epogen.With the Nephrology Business Unit strategy team, developed commercial strategies utilizing market research, competitive intelligence, war gaming workshops, and pricing and reimbursement studies to strengthen Amgen brands and prepare for potential competition entering the $3 billion US EPO market.Managed Competitive Intelligence (CI) assessing key intelligence questions and response plan - integrated CI into the strategy development process (war-gaming), helping lay out the frameworks for our US and Global commercial strategies resulting in 70 tactical work-streams to protect our Aranesp revenue stream in the worst case scenario that Roche prevail in the infringement case related to their new market entrant Peg-EPO. (Amgen won)Developed a new sales channel (Hospital Inside Sales – Amgen Commercial Operations 2005 Impact Award Winner) for Aranesp® in the small hospital market, tripling market share in six months and driving over $15MM in incremental sales from a $300k spendLed marketing initiative to develop tools to assist patients with rheumatoid arthritis self-administer Enbrel®, based on nurse and patient market research that I designed and conducted. Selected and managed the product engineering firm that designed and manufactured the Self Administration and Cap Removal Tools included with every new patient starter kit (winner of a 2003 Arthritis Foundation prize).

Volunteer math and physics teacher for 10th and 11th grade high school students.

Management consultant in the consumer goods practice of Booz, Allen and Hamilton (now Booz and Company). My primary clients were a Fortune 100 beverage company undergoing a restructuring of its sales and marketing organization and an international automotive/trucking manufacturer seeking help in opening up new distribution channels.

The Moses Lake facility known as Advanced Silicon Materials, Inc. (ASiMI) is now REC Silicon, a global manufacturer of polysilicon and silane gas used in the electronics and solar panel industries.Led the installation of a $56 million plant expansion, including a 20,000 sq. ft. semiconductor manufacturing building, 16 TDF-J vapor decomposition reactors and external support utilities. Co-Inventor and lead mechanical engineer of TDF-J, a vapor decomposition reactor. The TDF-J increased production of polycrystalline silicon by 400% at a critical time when sales were limited by overall plant output.Designed various polycrystalline silicon production equipment, including reactor extraction robots and reactor cleaning devices used in the day to day operations of polysilicon production.